Navigation Links
A grim dilemma: Treating the tortured prisoner
Date:5/9/2011

(Garrison, NY) Medical involvement with torture is prohibited by international law and professional associations, and yet sometimes it is the right thing for doctors to do, argue two bioethicists. Their timely paper in the Hastings Center Report comes as news of the trail leading to the death of Osama Bin Laden points to prisoners at Guantanamo Bay who were subject to "enhanced interrogation techniques," which many believe amounted to torture.

Despite its prohibition, torture remains widespread in more than a third of countries, according to data from Amnesty International cited in the article. And physicians and other medical personnel are implicated in at least 40 percent of cases, the article reports. Recently declassified documents from the Central Intelligence Agency on interrogation at Guantanamo Bay state, "OMS [Office of Medical Services] provided comprehensive medical attention to detainees . . . where Enhanced Interrogation Techniques were employed with high value detainees."

The dilemma physicians finds themselves in, according to authors Chiara Lepora and Joseph Millum, is that to care for tortured patients at the request of their torturers may "entail assisting or condoning terrible acts," but to refuse may in some cases mean abandoning a patient in need of a doctor's care or who desires such care. Chiara Lepora, M.D., is a visiting professor at the Korbel School of International Studies at the University of Denver who formerly worked for Doctors Without Borders as physician and emergency coordinator. Joseph Millum, Ph.D. has a joint appointment with the Clinical Center Department of Bioethics and the Fogarty International Center at the National Institutes of Health.

While complicity is wrong, Lepora and Millum contend that there are degrees of complicity, and it can be outweighed by other factors, such as the tortured prisoner's desire for treatment. They argue that dilemmas facing physicians arise because different principles, such as refraining from doing harm and respecting a patient's wishes, come in conflict with each other. As a result, they write, "This dilemma is real and . . . sometimes the right thing for a doctor to do, overall, is to be complicit in torture."

The authors provide guidelines to physicians for minimizing complicity, including assessing the consequences of their actions for themselves, the patient, and possibly society, and attempting to discern and follow the requests of the patient. Physicians can minimize complicity by ensuring that their actions do not share the wrongful intentions of the torturers and that they perform the physician role in such a way at to "mitigate, prevent, or help redress acts of torture." For example, a physician could secretly collect data to be used by groups investigating torture. The authors note that physicians who have been coerced into assisting with torture have often been among the first sources for international tribunals redressing the torture.

Despite their recommendations for individual physicians, the authors do not endorse altering professional and legal prohibitions against physician involvement in torture, because these powerful condemnations offer aspiration to a world without torture and they can help doctors avoid involvement. But the authors do recommend a case-by-case approach to enforcement that considers the challenges and ethical complexities for physicians in countries where torture is widespread, as well as the willingness of some doctors to compromise themselves for the sake of their patients.

"Other things being equal, it is better for a physician not to be complicit in torture," the authors conclude. "But other things are rarely equal and . . . a physician ought sometimes to accept complicity in torture for other moral reasons."


'/>"/>

Contact: Michael Turton
turtonm@thehastingscenter.org
845-424-4040 x242
The Hastings Center
Source:Eurekalert

Related medicine news :

1. Day care dilemma: When sick children are unnecessarily sent home
2. Blood Draw Dilemma: New Summit Health Article Helps Employers Choose the Best Screening Method
3. Treating Kids for Environmental Ills Costs U.S. $76B a Year
4. Animal studies reveal new route to treating heart disease
5. New gene therapy technique on iPS cells holds promise in treating immune system disease
6. NIH study finds Avastin and Lucentis are equally effective in treating AMD
7. Possible new approach to treating deadly leukemia in babies
8. Experts issue recommendations for evaluating and treating pituitary incidentalomas
9. Treating newborn horses: A unique form of pediatrics
10. Cancer drug shows promise for treating scleroderma
11. Weight-loss surgery successful in treating overweight adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 2017 , ... Pivot Point Consulting, a ... the firm’s new Consulting Services Executive. Mr. Tisch will oversee all aspects of ... clients with initial vendor selection and pre-implementation planning through go-live support and post-live ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: a captivating and ... named Edward Koontz. “To Walk Away” is the creation of published author, Larry R. ... two hundred manuscripts in chemistry and religion, as well as four novels. , ...
(Date:8/22/2017)... Carolina (PRWEB) , ... August 22, 2017 , ... ... advisor. Mr. Stewart is the Founder and Managing Member for t4 Leadership Development ... have become critical to his definition of “success”: physician leadership development, servant leadership, ...
(Date:8/21/2017)... Yorba Linda, Ca (PRWEB) , ... August 22, ... ... for numerous industries, but not without risk to health and safety. By learning ... risks could be eliminated. , In this webinar, attendees will gain a ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior assisted living ... Center. , Guests will be able to vote for their favorite Chef among ... with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/31/2017)... MEMPHIS, Tenn. , July 31, 2017 Three Tru-D ... in Yongsan, South Korea . Tru-D, short for "Total ... patient and operating rooms after an environmental services (ES) professional cleans the ... ... "Although ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: